Kinard David S 4
4 · Elanco Animal Health Inc · Filed Mar 3, 2026
Insider Transaction Report
Form 4
Kinard David S
SEE REMARKS
Transactions
- Award
Common Stock
[F1]2026-03-01+33,087→ 223,604 total - Tax Payment
Common Stock
2026-03-01$26.40/sh−15,377$405,953→ 208,227 total - Award
Common Stock
[F2]2026-03-01+9,470→ 217,697 total - Award
Employee Stock Option (right to buy)
[F3]2026-03-01+19,350→ 19,350 totalExercise: $26.40Exp: 2036-03-01→ Common Stock (19,350 underlying)
Footnotes (3)
- [F1]Includes 648 shares acquired on April 30, 2025, 518 shares acquired on July 31, 2025, 221 shares acquired on October 31, 2025, and 252 shares acquired on January 31, 2026 under Elanco Animal Health Inc.'s Employee Stock Purchase Plan .
- [F2]Grant of restricted stock units vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029.
- [F3]Grant of stock options vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029.
Signature
/s/ Amy C. Seidel, as Attorney-in-Fact for David S. Kinard|2026-03-03